Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bieke Lambert

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|July 21, 2005
Treatment of hepatocellular carcinoma by means of radiopharmaceuticalsBieke Lambert, Christophe Van de Wiele
Nuclear Medicine Communications|February 16, 2006
Clinical applications of 188Re-labelled radiopharmaceuticals for radionuclide therapyBieke Lambert, John M H de Klerk
Cancer Biotherapy & Radiopharmaceuticals|March 1, 2012
In vitro 2-deoxy-2-[18F]fluoro-D-glucose uptake: practical considerationsKoen Mertens, Gilles Mees, Bieke Lambert, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 15, 2010
PET with (18)F-labelled choline-based tracers for tumour imaging: a review of the literatureKoen Mertens, Dominique Slaets, Bieke Lambert, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 5, 2010
99mTc-labelled macroaggregated albumin (MAA) scintigraphy for planning treatment with 90Y microspheresBieke Lambert, Jeroen Mertens, Emiel J Sturm, et al.
Theranostics|November 22, 2017
Quantitative Imaging for Targeted Radionuclide Therapy Dosimetry - Technical ReviewTiantian Li, Edwin C I Ao, Bieke Lambert, et al.
The Prostate|January 8, 2014
Prognostic factors influencing prostate cancer-specific survival in non-castrate patients with metastatic prostate cancerPiet Ost, Karel Decaestecker, Bieke Lambert, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 28, 2011
Intra-arterial treatment with ⁹⁰Y microspheres for hepatocellular carcinoma: 4 years experience at the Ghent University HospitalBieke Lambert, Emiel Sturm, Jeroen Mertens, et al.
Clinical Nuclear Medicine|February 25, 2021
Bone SPECT/CT in the Evaluation of Painful Total Ankle Replacement: Validation of Localization Scheme and Preliminary Evaluation of Diagnostic PatternsJeroen Mertens, Tom Lootens, Johan Vercruysse, et al.
Radiation Research|May 27, 2004
Renal toxicity after radionuclide therapyBieke Lambert, Markus Cybulla, Stefan M Weiner, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
European Journal of Nuclear Medicine and Molecular Imaging|July 21, 2005
Treatment of hepatocellular carcinoma by means of radiopharmaceuticalsBieke Lambert, Christophe Van de Wiele
Nuclear Medicine Communications|February 16, 2006
Clinical applications of 188Re-labelled radiopharmaceuticals for radionuclide therapyBieke Lambert, John M H de Klerk
Cancer Biotherapy & Radiopharmaceuticals|March 1, 2012
In vitro 2-deoxy-2-[18F]fluoro-D-glucose uptake: practical considerationsKoen Mertens, Gilles Mees, Bieke Lambert, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 15, 2010
PET with (18)F-labelled choline-based tracers for tumour imaging: a review of the literatureKoen Mertens, Dominique Slaets, Bieke Lambert, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 5, 2010
99mTc-labelled macroaggregated albumin (MAA) scintigraphy for planning treatment with 90Y microspheresBieke Lambert, Jeroen Mertens, Emiel J Sturm, et al.
Theranostics|November 22, 2017
Quantitative Imaging for Targeted Radionuclide Therapy Dosimetry - Technical ReviewTiantian Li, Edwin C I Ao, Bieke Lambert, et al.
The Prostate|January 8, 2014
Prognostic factors influencing prostate cancer-specific survival in non-castrate patients with metastatic prostate cancerPiet Ost, Karel Decaestecker, Bieke Lambert, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 28, 2011
Intra-arterial treatment with ⁹⁰Y microspheres for hepatocellular carcinoma: 4 years experience at the Ghent University HospitalBieke Lambert, Emiel Sturm, Jeroen Mertens, et al.
Clinical Nuclear Medicine|February 25, 2021
Bone SPECT/CT in the Evaluation of Painful Total Ankle Replacement: Validation of Localization Scheme and Preliminary Evaluation of Diagnostic PatternsJeroen Mertens, Tom Lootens, Johan Vercruysse, et al.
Radiation Research|May 27, 2004
Renal toxicity after radionuclide therapyBieke Lambert, Markus Cybulla, Stefan M Weiner, et al.
Pageof 5